Epcoritamab + R2 regimen and responses in patients with high-risk follicular lymphoma, regardless of POD24 status Meeting Abstract
| Authors: | Merryman, R. W.; Belada, D.; Sureda, A.; Leppä, S.; Vermaat, J. S. P.; Holte, H.; Hutchings, M.; Lugtenburg, P.; de Vos, S.; Abrisqueta, P.; Nijland, M.; Christensen, J. H.; Wahlin, B. E.; Linton, K. M.; Wang, L.; Abbas, A.; Rana, A.; Quadri, S.; Falchi, L. |
| Abstract Title: | Epcoritamab + R2 regimen and responses in patients with high-risk follicular lymphoma, regardless of POD24 status |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | hematologic malignancy; follicular lymphoma; non-hodgkin lymphoma; phase i/ii; bispecific; ibcl |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S454 |
| Language: | English |
| ACCESSION: | WOS:001062479600495 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01362-9 |
| Notes: | Meeting Abstract: IBCL-474 -- Source: Wos |
